N 2 (199) 2026. P. 105–111

PHARMACEUTICAL SAFETY OF THE STATE: RESULTS OF EXPERT ASSESSMENT

O. B. Pankevych, B. P. Hromovyk

State Nonprofit Company “Danylo Halytsky Lviv National Medical University”, Lviv, Ukraine

DOI 10.32782/2226-2008-2026-2-15

Introduction. In the context of current threats posed by the full-scale Russian armed aggression, approaches to understanding the development of the state’s pharmaceutical safety (PS) require more in-depth investigation.

The aim of the work. To investigate the state of PS in Ukraine based on the views of the expert community, identify its components by importance, and determine how PS integrates into the national security system and contributes to the achievement of the UN Sustainable Development Goals.

Materials and methods. Scientific, analytical, legislative, and regulatory sources on national security and PS in Ukraine were used, incorporating methods including observation, survey, mathematical statistics, comparison, and generalization.

Results. Based on an expert evaluation conducted with the participation of 166 specialists drawn from scientific research, education, and practical pharmacy, a ranking was established to determine the relative importance and priorities of PS components. Additionally, the study assessed the degree of interrelation and influence these components exert on national security in the context of PS. Furthermore, the significance of advancing PS in alignment with the United Nations Sustainable Development Goals was identified.

Conclusions. The state of PS in Ukraine has been assessed in terms of its multidimensional structure, the interconnectedness of its components, and their influence on national security. A close connection between PS and the UN Sustainable Development Goals has been established, underscoring the need for a systemic approach to its development.

Keywords: national security, its components and priorities, pharmaceutical safety, pharmaceutical sector of the healthcare system, sustainable development goals.

REFERENCES

  1. Hromovyk BP, Pankevych OB. The role and place of pharmaceutical security in the national security system. Odesa Med J. 2024;(4):78–83 (In Ukrainian). https://doi.org/10.32782/2226-2008-2024-4-13.
  2. Elbe S. The pharmaceuticalisation of security: Molecular biomedicine, antiviral stockpiles, and global health security. Rev Int Stud. 2014;40(5):919–938. https://doi.org/10.1017/S0260210514000151.
  3. Saxena K, Balani S, Srivastava P. The role of pharmaceutical industry in building resilient health system. Front Public Health. 2022;10:964899. https://doi.org/10.3389/fpubh.2022.964899.
  4. European Commission. Proposal for a Regulation of the European Parliament and of the Council laying down a framework for strengthening the availability and security of supply of critical medicinal products (COM(2025) 102 final). Brussels: European Commission; 2025. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/ PDF/?uri=CELEX:52025PC0102.
  5. Thompson A. Transparency and accountability in pharmaceutical and health systems: Implications for patient trust and safety. J Pharm Health Serv Res. 2025;16(1). https://doi.org/10.1093/jphsr/rmaf003.
  6. World Health Organization. Access to safe, effective and quality-assured health products and technologies: Roadmap for WHO action 2025–2030. Geneva: WHO; 2025. Available from: https://www.who.int/publications/i/item/97892401
  7. Datsko AY, Datsko OI. Teoretyko-metodolohichni zasady formuvannia farmatsevtychnoi bezpeky derzhavy [Theoretical and methodological principles of forming pharmaceutical safety of the state]. In: Hromovyk BP, editor. Modern aspects of pharmaceutical practice in Ukraine: collective monograph. Lviv: Liga-Press; 2014. p. 11–36 (In Ukrainian).
  8. Voronina IS. Pharmaceutical security as a component of economic security of the state in terms of innovative models of social and economic development. Pravo Innovatsiine Suspilstvo. 2016;2(7):24–28 (In Ukrainian). Available from: https:// apir.org.ua/wp-content/uploads/2016/12/Voronina7.pdf.
  9. Belous-Sergeeva S. Research of pharmaceutical security as a component of economic security of the state. Visuomenes Saugumas Viesoji Tvarka. 2020;25:5–15. https://doi.org/10.13165/PSPO-20-25-01.
  10. Tkachenko N, Pankevych O, Mahanova T, Hromovyk B, Lesyk R, Lesyk L. Human Healthcare and Its Pharmacy Component from a Safety Point of View. Pharmacy (Basel). 2024;12(2):64. https://doi.org/10.3390/pharmacy12020064.
  11. Tkachenko NО, Mysyura SS. Expert assessment of the quality of pharmaceutical information in the area of patient safety and pharmaceutical safety. Farm Zh. 2024;(5):3–25 (In Ukrainian). https://doi.org/10.32352/0367-3057.5.24.01.
  12. Novikova OF, Sydorchuk OG, Pankova OV, et al. Stan ta perspektyvy sotsialnoi bezpeky v Ukraini: ekspertni otsinky [State and prospects of social security in Ukraine: expert assessments]: monograph. Kyiv-Lviv: LRIDU NANU; 2018. 184 p. (In Ukrainian).
  13. Kang M, Ragan BG, Park JH. Issues in outcomes research: an overview of randomization techniques for clinical trials. J Athl Train. 2008 Apr-Jun;43(2):215–21. https://10.4085/1062-6050-43.2.215.
  14. Janse RJ, Hoekstra T, Jager KJ, Zoccali C, Tripepi G, Dekker FW, et al. Conducting correlation analysis: important limitations and pitfalls. Clin Kidney J. 2021;14(11):2332–2337. https://doi.org/10.1093/ckj/sfab085.
  15. Bigunova NO. On the normative scale of evaluation. Nova Filolohiia. 2021;81(1):25–32 (In Ukrainian). https://doi.org/ 10.26661/2414-1135-2021-81-1-4.
  16. United Nations. Transforming our world: the 2030 Agenda for Sustainable Development. New York: UN; 2015. Available from: https://sdgs.un.org/2030agenda.
  17. President of Ukraine. Ukaz Prezydenta Ukrainy vid 30 veresnia 2019 roku No. 722/2019 “Pro Tsili staloho rozvytku Ukrainy na period do 2030 roku” [Decree of the President of Ukraine On the Sustainable Development Goals of Ukraine for the period up to 2030 dated September 30, 2019 No. 722/2019]. 2019. (In Ukrainian). Available from: https://www.president.gov.ua.
View article PDF